[AKRO] QoQ Quarter Result on 31-Dec-2018 [#Q4]

Stock
[AKRO] Akero Therapeutics, Inc.
Announcement Date
31-Dec-2018
Financial Year
2018
Quarter
31-Dec-2018 [#Q4]
Profit Trend
QoQ- -451.42%
YoY- -5,891.42%
Quarter Report
AKRO's Result
AKRO's Financial Summary
View:
Show?
Quarter Result
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -15,554 -7,228 -5,362 -61,472 -11,148 -8,673 -421 1006.84%
Tax -16,309 -7,609 -5,362 -2,968 0 -8,662 -421 1042.34%
NP -15,554 -7,228 -5,362 -61,472 -11,148 -8,673 -421 1006.84%
Tax Rate - - - - - - - -
Total Cost 15,554 7,228 5,362 61,472 11,148 8,673 421 1006.84%
Ratio Analysis
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
EPS -0.56 -2.21 -0.20 -2.90 -0.53 -0.41 -0.02 820.22%
EPS Diluted -0.56 -2.21 -0.20 -2.90 -0.53 -0.41 -0.02 820.22%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.